Isidro Olavide

Dr. Isidro Olavide

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2011 in Journal of Cardiothoracic Surgery
Verified
Journal Article
Open access
PDF file
ADAngelo Maria Dell´Aquila
Angelo Maria Dell´Aquila
SMStefano Mastrobuoni
Stefano Mastrobuoni
AGAlina Gallo
Alina Gallo
IOIsidro Olavide
Isidro Olavide
AMAlejandro Martin-Trenor
Alejandro Martin-Trenor
Endovascular stent grafting has been recently considered as a less invasive alternative to either medical therapy or open surgical treatment for many patients with descending thoracic aortic disease. Late complications are rarely described in literature. Herein, we described the occurrence of an aorto-bronchial fistula and a retro-A dissection in a 73-year-old man after stent-grafting for a penetrating atherosclerotic ulcer (PAU) of the descending thoracic aorta and the successful surgical technique adopted in order to remove the stent-graft.

31 August 2023 in Anales del Sistema Sanitario de Navarra
Verified
Journal Article
Open access
IRIñigo Rubio-Baines
Iñigo Rubio-Baines
MAMartinez-Simon Antonio
Martinez-Simon Antonio
FAFrancisco Javier Ancizu
Francisco Javier Ancizu
IOIsidro Olavide
Isidro Olavide
CHCristina Maria Honorato-Cia
Cristina Maria Honorato-Cia
Robot-assisted radical prostatectomy is a relatively recent technique. Its advantages include less invasiveness and better pain management, but has specific anesthesia requirements, such as steep Trendelenburg position and pneumoperitoneum. Mild complications are common, e.g., transient hypotension or soft tissue edema. We present a case of a 62-year old male who developed subgaleal hematoma associated with transient neurologic impairment after surgery. Jugular vein insufficiency was suspected as the most likely cause. The patient recovered fully. Robot-assisted radical prostatectomy can be a challenging procedure due to the anesthesia requirements, but most complications are mild and transient. However, patients should be carefully assessed before surgery. We identified potential factors that may have led to this complication: the abnormal prolonged surgical time, the steep Trendelenburg, a non-assessed jugular vein insufficiency, and/or patient`s obesity.

4 November 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
IOIsidro Olavide
Isidro Olavide
PMPablo Montero-Lopez
Pablo Montero-Lopez
Marc VivesMarc Vives
Marc Vives
Cardiac surgery is increasingly performed in older, frailer patients with multimorbidity, making postoperative recovery dependent not only on technical success but also on the quality of perioperative care. Enhanced Recovery After Surgery (ERAS) programs address this challenge through coordinated preoperative optimization, attenuation of surgical stress, organ protection, opioid-sparing analgesia, early mobilization, and structured discharge. This narrative review critically appraises ERAS in cardiac surgery and organizes the evidence across the perioperative pathway. Available studies associate complete ERAS programs with modest reductions in intensive care and hospital length of stay and possible reductions in overall complications, but evidence certainty is limited by heterogeneous bundles, single-center designs, and predominance of observational studies. Component-level evidence is strongest or clinically most relevant for frailty assessment, Patient Blood Management, multimodal analgesia, oxygen delivery-guided perfusion, delirium prevention, and early mobilization, although universal thresholds and isolated technologies should be avoided. Successful implementation depends on multidisciplinary governance, explicit responsibilities, adherence measurement, audit, and patient-centered outcomes. Future development should retain a standardized core while allowing transparent adaptation to baseline risk and observed response. Precision perioperative approaches remain hypothesis-generating and require external validation, clinical impact evaluation, assessment of equity, and demonstration of cost-effectiveness before routine adoption.